Header cover image

U.S. Pharmaceuticals & Biotech Your first investment

Results

5

0 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

5 companies

Johnson & Johnson

Market Cap: US$480.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

JNJ

US$200.00

7D

3.2%

1Y

30.7%

Merck

Market Cap: US$230.5b

Operates as a healthcare company worldwide.

MRK

US$96.43

7D

6.0%

1Y

-0.1%

Gilead Sciences

Market Cap: US$157.8b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

GILD

US$127.18

7D

3.1%

1Y

43.5%

Pfizer

Market Cap: US$142.6b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

PFE

US$25.45

7D

-0.2%

1Y

1.4%

Zoetis

Market Cap: US$52.4b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

ZTS

US$118.14

7D

-1.6%

1Y

-32.7%